PIAA

CAS No. 851814-28-3

PIAA( —— )

Catalog No. M16191 CAS No. 851814-28-3

PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PIAA
  • Note
    Research use only, not for human use.
  • Brief Description
    PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells.
  • Description
    PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells; downregulates polyinosine:polycytidylic acid (poly I:C)-stimulated phosphorylation of interferon responsive factor-3 (IRF3), a substrate of TBK1/IKKε; augments β-cell-specific proliferation by increasing cAMP levels and mTOR activity via PDE3, improves glucose control and β-cell mass in the STZ-induced diabetic mouse model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IκB kinase (IKK)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    851814-28-3
  • Formula Weight
    265.268
  • Molecular Formula
    C16H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C(C=C1)C2=C3C=C(C=CC3=NO2)C=CC(=O)O
  • Chemical Name
    (E)-3-(3-phenylbenzo[c]isoxazol-5-yl)acrylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu J, et al. Sci Rep. 2018 Oct 22;8(1):15587.
molnova catalog
related products
  • TBK1/IKKε-IN-5

    TBK1/IKKε-IN-5 ?is a dual TBK1 and IKKε inhibitor(IC50 of 1 nM and 5.6 nM respectively).

  • Rosiglitazone HCl

    Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

  • BAY-985

    BAY-985 is a potent, selective, and orally active ATP-competitive dual inhibitor of TBK1 and IKKε (IC50s: 2/30 and 2 nM for TBK1 (low/high ATP) and IKKε) with antitumor efficacy.BAY-985 inhibits FLT3, RSK4, DRAK1, and ULK1 (IC50s: 123, 276, 311, and 7930 nM). BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 (IRF3, IC50: 74 nM).